These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 17552998

  • 1. Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone.
    Maj PF, Collu M, Fadda P, Cattaneo A, Racagni G, Riva MA.
    Eur J Neurosci; 2007 Jun; 25(11):3305-11. PubMed ID: 17552998
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
    Antonelli T, Tanganelli S, Tomasini MC, Finetti S, Trabace L, Steardo L, Sabino V, Carratu MR, Cuomo V, Ferraro L.
    Neuroscience; 2004 Jun; 124(2):367-75. PubMed ID: 14980386
    [Abstract] [Full Text] [Related]

  • 3. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.
    Antonelli T, Tomasini MC, Tattoli M, Cassano T, Tanganelli S, Finetti S, Mazzoni E, Trabace L, Steardo L, Cuomo V, Ferraro L.
    Cereb Cortex; 2005 Dec; 15(12):2013-20. PubMed ID: 15788701
    [Abstract] [Full Text] [Related]

  • 4. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex.
    Castaldo P, Magi S, Gaetani S, Cassano T, Ferraro L, Antonelli T, Amoroso S, Cuomo V.
    Neuropharmacology; 2007 Sep; 53(3):369-78. PubMed ID: 17631920
    [Abstract] [Full Text] [Related]

  • 5. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):11-9. PubMed ID: 17644084
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
    Alén F, Santos A, Moreno-Sanz G, González-Cuevas G, Giné E, Franco-Ruiz L, Navarro M, López-Moreno JA.
    Neuroscience; 2009 Jan 23; 158(2):465-73. PubMed ID: 18977415
    [Abstract] [Full Text] [Related]

  • 7. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring.
    Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M.
    Neuroscience; 2011 Jan 13; 172():139-52. PubMed ID: 20969930
    [Abstract] [Full Text] [Related]

  • 8. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
    Benagiano V, Lorusso L, Flace P, Girolamo F, Rizzi A, Sabatini R, Auteri P, Bosco L, Cagiano R, Ambrosi G.
    Neuroscience; 2007 Nov 09; 149(3):592-601. PubMed ID: 17916407
    [Abstract] [Full Text] [Related]

  • 9. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P, Parviz M, Keshavarz M, Javanmardi K.
    Clin Exp Pharmacol Physiol; 2007 Nov 09; 34(5-6):439-49. PubMed ID: 17439413
    [Abstract] [Full Text] [Related]

  • 10. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes.
    Wang SJ.
    Eur J Pharmacol; 2003 May 23; 469(1-3):47-55. PubMed ID: 12782184
    [Abstract] [Full Text] [Related]

  • 11. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
    Carletti F, Gambino G, Rizzo V, Ferraro G, Sardo P.
    Neuroscience; 2015 Sep 10; 303():149-59. PubMed ID: 26135674
    [Abstract] [Full Text] [Related]

  • 12. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
    Carletti F, Gambino G, Rizzo V, Ferraro G, Sardo P.
    Epilepsy Res; 2016 May 10; 122():56-65. PubMed ID: 26970948
    [Abstract] [Full Text] [Related]

  • 13. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
    Saez TM, Aronne MP, Caltana L, Brusco AH.
    J Neurochem; 2014 May 10; 129(4):637-48. PubMed ID: 24329778
    [Abstract] [Full Text] [Related]

  • 14. Induction of cannabinoid- and N-methyl-D-aspartate receptor-mediated long-term depression in the nucleus accumbens and dorsolateral striatum is region and age dependent.
    Zhang X, Feng ZJ, Chergui K.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(4):. PubMed ID: 25618403
    [Abstract] [Full Text] [Related]

  • 15. Differential modulation of brainstem phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling underlies WIN55,212-2 centrally mediated pressor response in conscious rats.
    Ibrahim BM, Abdel-Rahman AA.
    J Pharmacol Exp Ther; 2012 Jan 24; 340(1):11-8. PubMed ID: 21946192
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA.
    Mol Pharmacol; 2006 Mar 24; 69(3):691-6. PubMed ID: 16299067
    [Abstract] [Full Text] [Related]

  • 17. Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy.
    Rizzo V, Carletti F, Gambino G, Schiera G, Cannizzaro C, Ferraro G, Sardo P.
    Epilepsy Res; 2014 Dec 24; 108(10):1711-8. PubMed ID: 25458534
    [Abstract] [Full Text] [Related]

  • 18. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.
    Antonelli T, Tomasini MC, Tattoli M, Cassano T, Finetti S, Mazzoni E, Trabace L, Carratù MR, Cuomo V, Tanganelli S, Ferraro L.
    Neurochem Int; 2006 Nov 24; 49(6):568-76. PubMed ID: 16777266
    [Abstract] [Full Text] [Related]

  • 19. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ9-THC exposure.
    Beggiato S, Borelli AC, Tomasini MC, Morgano L, Antonelli T, Tanganelli S, Cuomo V, Ferraro L.
    Neurobiol Learn Mem; 2017 Mar 24; 139():135-143. PubMed ID: 28104530
    [Abstract] [Full Text] [Related]

  • 20. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ, Wu HJ, Wang SY, Yin S, Lu XJ, Miao Y, Wang XH, Yang XL, Wang Z.
    Neuroscience; 2013 Dec 03; 253():183-93. PubMed ID: 24013008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.